The 2006 Cancer Strategy recommended that national, site-specific, multi-disciplinary groups should be convened to develop evidence based guidelines for common cancers.
The National Cancer Care Programme (NCCP) Guidelines Development Group supports the development of national clinical guidelines around cancer care.
The NCCP recognise the importance of patient input and their role as key stakeholders in informing quality improvements in our healthcare system. Patients are engaged via patients support & advocacy groups and
charities and invited to contribute to the development of the guideline from a patient’s perspective. This approach helps to capture the patient experience which encompasses important quality of life issues and patients values.
- Four patient organisations/groups were engaged in drafting the national clinical guidelines for diagnosis, staging and treatment of patients with colon cancer in December 2020
- Four patient organisations/groups were engaged in drafting the national clinical guidelines for diagnosis, staging and treatment of patients with rectal cancer in December 2020
- Two advocates from a patient organisation were engaged in drafting the national clinical guidelines for diagnosis, staging and treatment of patients with ovarian cancer in August 2019
- One patient organisation was engage in drafting the national clinical guidelines for diagnosis, staging and treatment of patients with oesophageal cancer in August 2019